Lasekan et al., 1992 - Google Patents
Energy expenditure in rats maintained with intravenous or intragastric infusion of total parenteral nutrition solutions containing medium-or long-chain triglyceride …Lasekan et al., 1992
View PDF- Document ID
- 11585667516611870487
- Author
- Lasekan J
- Rivera J
- Hirvonen M
- Keesey R
- Ney D
- Publication year
- Publication venue
- The Journal of nutrition
External Links
Snippet
Energy expenditure was determined in male Fischer 344 rats (235–246 g) fed by intravenous (IV) or intragastric (IG) infusion with total parenteral nutrition solutions providing 65% of nonprotein energy as fat from long-chain triglyceride (LCT) or a 3: 1 admixture of …
- 238000001802 infusion 0 title abstract description 134
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lasekan et al. | Energy expenditure in rats maintained with intravenous or intragastric infusion of total parenteral nutrition solutions containing medium-or long-chain triglyceride emulsions | |
| Hodges et al. | Pantothenic acid deficiency in man | |
| Klatskin et al. | Relationship between relapsing pancreatitis and essential hyperlipemia | |
| Houpt et al. | The pig as a model for the study of obesity and of control of food intake: a review | |
| AU2008239318B2 (en) | Anti-fatigue agent | |
| Chambers | Undernutrition and carbohydrate metabolism | |
| Gubler | Copper metabolism in man | |
| PT90732B (en) | METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS ADEQUATE TO BE EMPLOYED IN ALCOHOLISM THERAPY, BASED ON SALTS OF GAMA-HYDROXIBUTIRYTIC ACID | |
| Banks Jr et al. | Hepatic composition and metabolism after ethanol consumption in rats fed liquid purified diets | |
| Truss | Metabolic abnormalities in patients with chronic candidiasis | |
| Schwartzbaum et al. | An osmotic factor in the regulation of food intake in the rat. | |
| Robin et al. | Intravenous fat emulsion acutely suppresses neutrophil chemiluminescence | |
| Mendez et al. | Effects of different lipid sources in total parenteral nutrition on whole body protein kinetics and tumor growth | |
| Bernstein et al. | Effects of interference stimuli on the acquisition of learned aversions to foods in the rat. | |
| Yamazaki et al. | Hypocaloric lipid emulsions and amino acid metabolism in injured rats | |
| Bivins et al. | Parenteral safflower oil emulsion (Liposyn 10%): safety and effectiveness in treating or preventing essential fatty acid deficiency in surgical patients | |
| Walker et al. | The metabolic basis of surgical care | |
| Page et al. | Your Body Is Your Best Doctor!: Formerly, Health Versus Disease | |
| Grinker et al. | The effect of the metabolite glycerol on food intake and body weight in rats | |
| Bailey et al. | Total parenteral nutrition with short-and long-chain triglycerides: triacetin improves nitrogen balance in rats | |
| RU2436415C2 (en) | Composition of biologically active substances based on betulin with regulated rate of releasing components for reducing degree of alcohol intoxication, preventing and relieving alcohol intoxication and alcohol withdrawal syndrome | |
| Baker et al. | Plasma human growth hormone levels in response to meals: a reappraisal | |
| RU2598346C1 (en) | Method of treating and preventing dysmetabolic nephropathy in children associated with toxic action of cadmium, lead, chrome and phenol of anthropogenic origin | |
| Guzman et al. | Physical and intellectual development in Philippine children fed five different dietary staples | |
| Crosby et al. | Effect of structured lipid-enriched total parenteral nutrition in rats bearing Yoshida Sarcoma |